31th JSSX Annual Meeting in Matsumoto The Japanese Society for the Study of Xenobiotics

Sessions

Symposium

16 results  (1 - 10)

  • Symposium

Thu. Oct 13, 2016 9:00 AM - 11:30 AM Room 1 (Great hall)

Yoshiro Saito (National Institute of Health Sciences, Division of Medicinal Safety Science), Masahiro Tohkin (Graduate School of Pharmaceutical Sciences, Nagoya City University), Takafumi Iwatsubo (Drug Metabolism & Pharmacokinetics Management, Analysis & Pharmacokinetics Research Labs., Drug Discovery Research, Astellas Pharma Inc.)

  • Symposium

Thu. Oct 13, 2016 9:00 AM - 11:30 AM Room 4 (The second conference room)

Masahiro Utoh (Pharmacokinetics and Bioanalysis Center, Shin Nippon Biomedical Laboratories, Ltd.), Jun Hosogi (Kyowa Hakko Kirin Co.,Ltd. R&D Division Translational Research Unit), Ryoya Goda (Drug Metabolism & Pharmacokinetics Research Laboratories, R&D Division, Daiichi Sankyo Co., Ltd.)

  • Symposium

Thu. Oct 13, 2016 2:20 PM - 4:50 PM Room 1 (Great hall)

Miki Nakajima (Faculty of Pharmaceutical Sciences, Kanazawa University), Yuji Ishii (Laboratory of Molecular Life Sciences, Graduate School of Pharmaceutical Sciences, Kyushu University), Seigo Sanoh (Graduate School of Biomedical and Health Sciences, Hiroshima University)

  • Symposium

Fri. Oct 14, 2016 9:00 AM - 11:30 AM Room 3 (International conference room)

Kenji Tabata (Analysis & Pharmacokinetics Research Labs, Astellas Pharma Inc.), Koji Chiba (Laboratory of Clinical Pharmacology, Yokohama University of Pharmacy), Yasuhisa Nagasaka (Pharmacokinetics-Pharmacodynamics, Analysis & Pharmacokinetics Research Labs, Astellas Pharma Inc.), Teruki Hamada (Drug Metabolism & Pharmacokinetics Research Laboratories, Takeda Pharmaceutical Company Limited), Masayo Oishi (Clinical Pharmacology, Pfizer Japan Inc.), Akihiro Hisaka (Clinical Pharmacology and Pharmacometrics, Graduate School of Pharmaceutical Sciences, Chiba University), Noriko Okudaira (Drug Metabolism & Pharmacokinetics Research Laboratories, R&D Division, Daiichi Sankyo Co., Ltd.), Naomi Nagai (Pharmaceuticals and Medical Devices Agency)